Friday, April 3, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Expedia Stock: Soars to Record High on Stellar Earnings

Robert Sasse by Robert Sasse
August 9, 2025
in Stocks
0
Expedia Stock
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

Expedia’s shares surged 13.5% to a 52-week high of $212.06 on Friday, capping a 59.75% annual gain, fueled by stronger-than-expected Q2 results. The travel giant reported earnings of $4.24 per share, surpassing forecasts of $3.96, while revenue hit $3.79 billion against estimates of $3.7 billion. Key growth drivers included a 17% jump in B2B bookings and a 19% rise in advertising revenue, underscoring its robust international presence. Adjusted EBITDA margins expanded by 190 basis points to 24%, reflecting improved profitability.

Analysts Rally Behind Upgraded Targets

Wall Street responded with bullish price-target hikes, including raises to $218 (DA Davidson) and $240 (BofA). Efficiency gains—from job cuts and AI adoption—slashed overhead costs to 16.8% of revenue. While U.S. consumer demand remained subdued, international leisure bookings grew 13%, and CEO Ariane Gorin noted a recent uptick in American travel sentiment. Expedia raised its full-year booking growth forecast to 3–5%, with margins expected to improve by another 100 basis points. The stock’s pre-market spike to $216 signals sustained investor confidence.

Ad

Expedia Stock: Buy or Sell?! New Expedia Analysis from April 3 delivers the answer:

The latest Expedia figures speak for themselves: Urgent action needed for Expedia investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 3.

Expedia: Buy or sell? Read more here...

Tags: Expedia
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Eli Lilly Stock
Stocks

Eli Lilly’s Strategic Diversification Amid Weight-Loss Drug Competition

November 18, 2025
Micron Stock
Stocks

Micron Shares Approach Peak: What Comes After the AI Rally?

November 18, 2025
Varonis Stock
Stocks

Varonis Shares Plunge Amidst Mixed Signals

November 18, 2025
Next Post
Münchener Rück Stock

Münchener Rück Stock: Record Profit Masked by Market Jitters

Gilead Sciences Stock

Gilead Sciences Stock: HIV Success Fuels Analyst Optimism

The Trade Desk Stock

The Trade Desk Stock: Plunges 32% on Downgrade, Growth Fears

Recommended

Rigetti Stock

Quantum Computing Stock Rigetti Experiences Wild Price Swings

5 months ago
MP Materials Stock

U.S. Strategic Minerals Push Fuels Momentum for MP Materials

2 months ago
Universal Health Services Stock

Strategic Vision and Medicaid Windfall Propel Universal Health Services Shares Higher

7 months ago
Fintechwerx International So Stock

Fintechwerx Seeks European Payments Entry Through Gibraltar Venture

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Geopolitical Tensions Fuel Investor Interest in Oil & Gas ETF

TSMC’s Market Dominance Set to Deepen with Upcoming Results and Strategic Expansion

Kratos Defense Shares: A Volatile Day Driven by Insider Sales and Strategic Positioning

Visa’s Next Frontier: Securing Commerce Between Machines

Devon Energy Merger Clears Key Regulatory Review

The $99 Digital Employee: Enterprise Software’s Agentic Awakening

Trending

Eli Lilly Stock
AI & Quantum Computing

Eli Lilly’s Strategic Expansion: A Multi-Billion Dollar Push into Neurology and AI

by Jackson Burston
April 3, 2026
0

Pharmaceutical giant Eli Lilly is strategically expanding its empire beyond its blockbuster weight-loss drugs. In a series...

Amazon Stock

Amazon’s Fee Hike Puts Pressure on Marketplace Sellers

April 3, 2026
Harley-Davidson Stock

Harley-Davidson Gains Institutional Backing Amid Strategic Financial Moves

April 3, 2026
SPDR® S&P Oil & Gas Exploration & Production ETF Stock

Geopolitical Tensions Fuel Investor Interest in Oil & Gas ETF

April 3, 2026
TSMC Stock

TSMC’s Market Dominance Set to Deepen with Upcoming Results and Strategic Expansion

April 3, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Eli Lilly’s Strategic Expansion: A Multi-Billion Dollar Push into Neurology and AI
  • Amazon’s Fee Hike Puts Pressure on Marketplace Sellers
  • Harley-Davidson Gains Institutional Backing Amid Strategic Financial Moves

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com